Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 16/20 | 0.48 |
| ▸ | ESRRA | P11474 | 2/20 | 0.38 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8550194 | 0.88 | AR (0.44) | AR | |
| SCHEMBL7077280 | 0.81 | AR (0.71) | AR | |
| SCHEMBL18957656 | 0.81 | LMNA (0.46) | AR | |
| SCHEMBL7070246 | 0.80 | MEN1 (0.47) | AREPAS1 | |
| SCHEMBL875821 | 0.80 | POLB (0.51) | AR | |
| SCHEMBL7074662 | 0.79 | AR (0.56) | AR | |
| SCHEMBL15096324 | 0.79 | AR (0.59) | AR | |
| SCHEMBL30792697 | 0.76 | TRPV4 (0.53) | ARESRRA | |
| SCHEMBL1134140 | 0.76 | TRPV4 (0.53) | ARESRRA | |
| SCHEMBL7070749 | 0.75 | SMN1; SMN2 (0.50) | AREPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1272456-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | Abbott Laboratories (US) | 2003-01-08 | — | — | EP | claimed |
| WO-2001079157-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2001-10-25 | — | — | WO | claimed |
| US-20030181334-A1 | Herbicidal method | BAYER CROPSCIENCE LIMITED (GB) | 2003-09-25 | — | — | US | disclosed |
| WO-2003051119-A1 | NEW HERBICIDAL COMPOUNDS AND METHOD | BAYER CROPSCIENCE LIMITED (GB) | 2003-06-26 | — | — | WO | disclosed |
| EP-1272456-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | Abbott Laboratories (US) | 2003-01-08 | — | — | EP | disclosed |
| WO-2001079157-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2001-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181334-A1 | Herbicidal method | DDT, HAAO, CYP4X1 | AR 4356/4885ESRRA 2981/4885EPAS1 4199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.